Replies to post #198117 on Amfil Technologies Inc (FUNN)

[Juancy]

Nobody here disagrees that it has been a disappointing 2018 with respect to the audit, the PPS, and the pending catalysts that are relying on the audit completion. I know some might even regret buying here instead of elsewhere, but we all know the type of company we have here, and it should not be much longer before we are back on track.

Time can strip us of our patience and reasoning, but if we can step back and see the bigger picture, we can clearly see the potential here and the growth taking place before our eyes. JRF, MountainMain, and a few others wouldn't have invested their hard-earned money and time into S&L locations if they didn't see the potential with the company and the management. So I wait patiently, since 2019 will definitely be much better, IMO. ;-)

$AMFE

[User-65225]

When did Roger "promise" a date for the current filing?.. Heres the last update. I dont see a "promise"...

https://www.otcmarkets.com/stock/AMFE/news/Amfil-Technologies-Incs-GRO3-Division-Enters-Into-Exclusive-Agreement-with-Cannabis-Infused-Beverage-Maker-Kalvara-With-?id=209175

A note regarding Amfil’s “Stop Sign” designation on OTC Markets.

As shareholders are well aware, the company decided to undergo the process of auditing the last three years financial statements in order to up-list off the OTC Pink market. Fiscal year end June 30th, 2016 and 2017 audited statements have been filed and can be found at the following link: https://backend.otcmarkets.com/otcapi/company/financial-report/202464/content

The 2016/2017 audits took longer than anticipated and overflowed into the time allotted for the 2018 audit to be completed. Consequently, the company missed the Oct.15, 2018 filing deadline and a stop sign designation was issued from OTC Markets. The 2018 audit is currently underway and will be filed upon completion, which will remove the stop sign designation and enable the up-list of the company off the OTC Pink Market.

There is never an ideal time to complete a multi-year audit. The process is often time consuming, and it can cause unintentional by-products including the stop sign designation. It is, however, a necessity in terms of the greater progression and growth of the company in the long-term. The completion and filing of two of the previous three years audits is an enormous step forward in the process. The 2018 audit will be completed and filed, and the company is excited for its future beyond the OTC Pink market. Amfil, along with the internal and external accountants, the CFO Squad, and our auditors RBSM are dedicated to completing this final year’s audit as quickly and efficiently as possible. Once complete, the company will up-list off the OTC Pink market and begin the spinoff and dividend process mentioned in prior press.

[Las3r]

Completely disappointing imho